SEARCH

SEARCH BY CITATION

References

  • 1
    Cavenee WK, White RL. The genetic basis of cancer. Sci Am 1995; 272: 729.
  • 2
    Pavan WJ, Hieter P, Reeves RH. Modification and transfer into an embryonal carcinoma cell line of a 360-kilobase human-derived yeast artificial chromosome. Mol Cell Biol 1990; 10: 41639.
  • 3
    Murakami Y, Nobukuni T, Tamura K et al. Localization of tumor suppressor activity important in non-small cell lung carcinoma on chromosome 11q. Proc Natl Acad Sci USA 1998; 95: 81538.
  • 4
    Kuramochi M, Fukuhara H, Nobukuni T et al. TSLC1 is a tumor suppressor gene in human non-small cell lung cancer. Nat Genet 2001; 27: 42730.
  • 5
    Murakami Y. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer. Oncogene 2002; 21: 693648.
  • 6
    Gomyo H, Arai Y, Tanigami A et al. A 2MB sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2. Genomics 1999; 62: 13946.
  • 7
    Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci 2003; 94: 57581.
  • 8
    Sasaki H, Nishikata I, Shiraga T et al. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute type of adult T-cell leukemia. Blood 2005; 105: 120413.
  • 9
    Wakayama T, Ohashi K, Mizuno K, Iseki S. Cloning and characterization of a novel mouse immunoglobulin superfamily gene expressed in early spermatogenic cells. Mol Reprod Dev 2001; 60: 15864.
  • 10
    Ito A, Jippo T, Wakayama T et al. SgIGSF: a new mast-cell adhesion molecule used for attachment to fibroblasts and transcriptionally regulated by MITF. Blood 2003; 101: 26018.
  • 11
    Biederer T, Sara Y, Mozhayeva M et al. SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science 2002; 297: 152531.
  • 12
    Galibert L, Diemer GS, Liu Z et al. Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I restricted T-cell associated molecule. J Biol Chem 2005; 280: 21 95564.
  • 13
    Boles KS, Barchet W, Diacovo T, Cella M, Colonna M. The tumor suppressor TSLC1/NECL-2 triggers NK cell and CD8+ T cell responses through the cell surface receptor CRTAM. Blood 2005; 106: 77986.
  • 14
    Takai Y, Irie K, Shimizu K, Sakisaka T, Ikeda W. Nectins and nectin-like molecules. Roles in cell adhesion, migration, and polarization. Cancer Sci 2003; 94: 65567.
  • 15
    Fujita E, Soyama A, Momoi T. RA175, which is the mouse ortholog of TSLC1, a tumor suppressor gene in human lung cancer, is a cell adhesion molecule. Exp Cell Res 2001; 287: 5766.
  • 16
    Watabe K, Ito A, Koma YI, Kitamura Y. IGSF4: a new intercellular adhesion molecule that is called by three names, TSLC1, SgIGSF and SynCAM, by virtue of its diverse function. Histol Histopathol 2003; 18: 13219.
  • 17
    Yokota J, Kohno T. Molecular footprints of human lung cancer progression. Cancer Sci 2004; 95: 197204.
  • 18
    Tomida S, Yatabe Y, Yanagisawa K, Mitsudomi T, Takahashi T. Throwing new light on lung cancer pathogenesis: updates on three recent topics. Cancer Sci 2005; 96: 638.
  • 19
    Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002; 21: 691535.
  • 20
    Harris H, Miller OJ, Klein G, Worst P, Tachibana T. Suppression of malignancy by cell fusion. Nature 1969; 223: 3638.
  • 21
    Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG, Stanbridge EJ. Introduction of a normal human chromosome 11 into a Wilms’ tumor cell line controls its tumorigenic expression. Science 1987; 236: 17580.
  • 22
    Koi M, Johnson LA, Kalikin LM, Little PF, Nakamura Y, Feinberg AP. Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science 1993; 260: 3614.
  • 23
    Murakami Y, Brothman AR, Leach RJ, White RL. Suppression of malignant phenotype in a human prostate cancer cell line by fragments of normal chromosome 17q. Cancer Res 1995; 55: 338994.
  • 24
    Satoh H, Lamb PW, Dong JT et al. Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer. Mol Carcinog 1993; 7: 15764.
  • 25
    Iizuka M, Sugiyama Y, Shiraishi M, Jones C, Sekiya T. Allelic losses in human chromosome 11 in lung cancers. Genes Chromosomes Cancer 1995; 13: 406.
  • 26
    Fukami F, Fukuhara H, Kuramochi M et al. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines. Int J Cancer 2003; 107: 539.
  • 27
    Fukuhara H, Kuramochi M, Fukami T et al. Promoter methylation of the TSLC1 and tumor suppression by its gene product in human prostate cancer. Jpn J Cancer Res 2002; 93: 6059.
  • 28
    Ito T, Shimada Y, Hashimoto Y et al. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma. Cancer Res 2003; 63: 63206.
  • 29
    Honda T, Tamura G, Waki T et al. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines. Jpn J Cancer Res 2002; 93: 85760.
  • 30
    Jansen M, Fukushima N, Rosty C et al. Aberrant methylation of the 5′ CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs. Cancer Biol Ther 2002; 1: 2936.
  • 31
    Hui AB, Lo KW, Kwong J et al. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma. Mol Carcinog 2003; 38: 1708.
  • 32
    Lung H-L, Cheng Y, Kumaran MK et al. Fine mapping of 11q22–23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. Int J Cancer 2004; 112: 62835.
  • 33
    Allinen M, Peri L, Kujala S et al. Analysis of 11q21–24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation. Genes Chromosomes Cancer 2002; 34: 3849.
  • 34
    Steenbergen RD, Kramer D, Braakhuis BJ et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 2004; 96: 294305.
  • 35
    Surace EI, Murakami Y, Scheithauer BW, Perry A, Gutmann DH. Tumor suppressor in lung cancer-1 (TSLC1) expression is lost in sporadic meningioma. J Neuropathol Exp Neurol 2004; 63: 101527.
  • 36
    Uchino K, Ito A, Wakayama T et al. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung. Cancer 2003; 98: 10027.
  • 37
    Ito A, Okada M, Uchino K et al. Expression of the TSLC1 adhesion molecule in pulmonary epithelium and its down-regulation in pulmonary adenocarcinoma other than bronchioloalveolar carcinoma. Lab Invest 2003; 83: 117583.
  • 38
    Goto A, Niki T, Chi-pin L et al. Loss of TSLC expression in lung adenocarcinoma: Relationships with histological subtypes, sex and prognostic significance. Cancer Sci 2005; 96: 4806.
  • 39
    Masuda M, Yageta M, Fukuhara H et al. The tumor suppressor protein TSLC1 is involved in cell-cell adhesion. J Biol Chem 2002; 277: 31 014–9.
  • 40
    Kakunaga S, Ikeda W, Itoh S et al. Nectin-like molecule-1/TSLL1/SynCAM3: a neural tissue-specific immunoglobulin-like cell-cell adhesion molecule localizing at non-junctional contact sites of presynaptic nerve terminals, axons and glia cell processes. J Cell Sci 2005; 118: 12677.
  • 41
    Fukuhara H, Kuramochi M, Nobukuni T et al. Isolation of the TSLL1 and TSLL2 genes, members of the tumor suppressor TSLC1 gene family encoding transmembrane proteins. Oncogene 2001; 20: 54017.
  • 42
    Shingai T, Ikeda W, Kakunaga S et al. Implications of nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells. J Biol Chem 2003; 278: 35 421–7.
  • 43
    Yageta M, Kuramochi M, Masuda M et al. Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer. Cancer Res 2002; 62: 512933.
  • 44
    Sun CX, Robb VA, Gutmann DH. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. J Cell Sci 2002; 115: 39914000.
  • 45
    Fukuhara H, Masuda M, Yageta M et al. Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of drosophila tumor suppressor Dlg. Oncogene 2003; 22: 61605.
  • 46
    Bachmann A, Schneider M, Theilenberg E, Grawe F, Knust E. Drosophila Stardust is a partner of Crumbs in the control of epithelial cell polarity. Nature 2001; 414: 63843.
  • 47
    Tran YK, Bogler O, Gorse KM, Wieland I, Green MR, Newsham IF. A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer. Cancer Res 1999; 59: 3543.
  • 48
    Kikuchi S, Yamada D, Fukami T et al. Promoter methylation of the DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer. Clin Cancer Res 2005; 11: 295461.
  • 49
    Gutmann DH, Donahoe J, Perry A et al. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet 2000; 9: 1495500.
  • 50
    Mao X, Seidlitz E, Ghosh K, Murakami Y, Ghosh HP. The cytoplasmic domain is critical to the tumour suppressor activity of TSLC1 in non-small cell lung cancer. Cancer Res 2003; 63: 797985.
  • 51
    Mao X, Seidlitz E, Truant R, Hitt M, Ghosh HP. Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth. Oncogene 2004; 23: 563242.
  • 52
    Takatsuki K. Discovery of adult T-cell leukemia: reminiscences. In: SugamuraK, UchiyamaT, MatsuokaM, KannagiM, eds. Two decades of adult T-cell leukemia and HTLV-1 research. Japanese Cancer Association Gann Monograph on Cancer Research No. 50. Tokyo: Japan Scientific Society Press 2003; 79.
  • 53
    Wakayama T, Koami H, Ariga H et al. Expression and functional characterization of the adhesion molecule spermatogenic immunoglobulin superfamily in the mouse testis. Biol Reprod 2003; 68: 175563.
  • 54
    Morii E, Ito A, Jippo T et al. Number of mast cells in the peritoneal cavity of mice: influence of microphthalmia transcription factor through transcription of newly found mast cell adhesion molecule, spermatogenic immunoglobulin superfamily. Am J Pathol 2004; 165: 4919.
  • 55
    Lindsey JC, Lusher ME, Anderton JA et al. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling. Carcinogenesis 2004; 25: 6618.